Crispr Therapeutics shares tumble after significant earnings miss
Monica L. Greenberg, EVP, Policy & General Counsel at Liveperson Inc (NASDAQ:LPSN), sold 7,431 shares of common stock on July 28, 2025, at a price of $1.026, for a total value of $7624.
Following the transaction, Greenberg directly owns 699,270 shares of Liveperson Inc, which includes 558,749 unvested restricted stock units. The sale was executed automatically by Liveperson Inc to cover Greenberg’s tax obligations related to the vesting of restricted stock units. The company is scheduled to report its next earnings on August 12, 2025. For deeper insights into Liveperson’s financial health and detailed analysis, investors can access the comprehensive Pro Research Report available on InvestingPro.
In other recent news, LivePerson Inc. reported its Q1 2025 earnings, revealing a notable shortfall in earnings per share (EPS) compared to analyst forecasts. The company reported an EPS of -$0.24, which was significantly below the expected -$0.06. However, revenue for the quarter was $64.7 million, slightly exceeding the midpoint of the company’s guidance. Additionally, shareholders at LivePerson’s virtual annual meeting approved an amendment to the Amended and Restated 2019 Stock Incentive Plan, increasing the shares of common stock available for issuance by 5,340,000. This amendment also stipulates that dividends or dividend equivalent rights related to awards will only be paid if the underlying award vests. In governance news, LivePerson announced the appointment of Tony Zingale to its Board of Directors. Zingale, a seasoned technology industry veteran, brings over 40 years of experience and currently serves on the boards of ON24 and other private companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.